Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07119970
NA

Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)

Sponsor: University Hospital, Bordeaux

View on ClinicalTrials.gov

Summary

Myeloproliferative neoplasms are hematologic diseases characterized by an increased proliferation of peripheral blood cells. The main risk of MPN is the occurrence of thrombosis. Thrombosis risk is mainly evaluated using two criteria: age and prior thrombosis. A better prediction of thrombosis risk is needed to improve prevention and treatment of MPN-associated thrombosis. The objective of the study is to evaluate the predictive value of neutrophil extracellular traps markers in thrombosis during MPN.

Official title: Prospective Study for the Evaluation of the Prognostic Value of NETosis Markers to Predict Thrombosis in Myeloproliferative Neoplasms With JAK2V617F Mutation (AVATARE)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

300

Start Date

2025-12-09

Completion Date

2030-12

Last Updated

2026-01-13

Healthy Volunteers

No

Interventions

BIOLOGICAL

Additional blood sampling

At inclusion (T0) and at 12 months (T1), venous blood will be drawn for plasma markers of NETosis

Locations (15)

CHU d'Angers, Service des maladies du Sang

Angers, France

CH de la Côte Basque, Service Hématologie

Bayonne, France

CHU de Bordeaux, Service Hématologie Biologique

Bordeaux, France

CHU de Bordeaux, Service Hématologie Clinique et Thérapie Cellulaire

Bordeaux, France

CHU de Brest, Service Hématologie et Hémostase Clinique

Brest, France

APHP-Hôpital Mondor, Service Hématologie Clinique et Thérapie Cellulaire

Créteil, France

CHD de Vendée, Service Onco-hématologie

La Roche-sur-Yon, France

APHP-Hôpital Bicêtre, Service Hématologie Clinique Ambulatoire

Le Kremlin-Bicêtre, France

CH de Libourne, Service Hématologie

Libourne, France

CHU de Limoges, Service Hématologie Clinique et de Thérapie Cellulaire

Limoges, France

CH des Pays de Morlaix, Service Onco-Hématologie

Morlaix, France

CHU de Nantes, Service Hématologie Clinique

Nantes, France

Hôpital Privé du Confluent, Service Hématologie

Nantes, France

APHO-Hôpital Saint-Louis, Centre d'Investigations Cliniques

Paris, France

CH de Roubaix, Service Hématologie

Roubaix, France